Skip to main content
. 2021 Aug 9;9:684112. doi: 10.3389/fpubh.2021.684112

Table 3.

Logistic regression analysis of the association between mental disorders and risk of death due to COVID-19.

Variables Death risk due to COVID-19
Model 1 Model 2 Model 3 Model 4
OR (95% CI) p-value OR (95% CI) p-value OR (95%CI) p-value OR (95% CI) p-value
Psychotic disorders 2.87 (1.22–6.75) 0.016 2.77 (1.10–7.01) 0.031 2.29 (0.82–6.37) 0.11 1.88 (0.68–5.23) 0.23
Substance use disorder 1.84 (1.40–2.41) <0.001 1.60 (1.20–2.14) 0.001 1.59 (1.18–2.16) 0.003 1.23 (0.90–1.69) 0.20
Bipolar affective disorder 4.50 (2.34–8.66) <0.001 4.50 (2.18–9.27) <0.001 4.77 (2.31–9.87) <0.001 3.69 (1.78–7.67) <0.001
Dementia 6.29 (4.70–8.42) <0.001 2.03 (1.49–2.76) <0.001 2.25 (1.63–3.10) <0.001 2.06 (1.49–2.85) <0.001
 Alzheimer disease 5.97 (4.29–8.32) <0.001 1.85 (1.31–2.63) 0.001 2.18 (1.52–3.11) <0.001 2.13 (1.48–3.06) <0.001
 Vascular dementia 3.71 (1.43–9.62) 0.007 1.20 (0.45–3.18) 0.71 1.33 (0.50–3.52) 0.57 0.91 (0.33–2.45) 0.84
 Secondary dementia 7.30 (4.26–12.53) <0.001 2.69 (1.53–4.75) 0.001 2.68 (1.47–4.88) 0.001 2.09 (1.13–3.85) 0.019
Anxiety 1.71 (1.19–2.44) 0.003 1.57 (1.07–2.29) 0.02 1.56 (1.06–2.31) 0.024 1.27 (0.85–1.89) 0.24
 Late-life anxiety 2.36 (1.64–3.39) <0.001 1.61 (1.10–2.35) 0.014 1.60 (1.09–2.37) 0.018 1.30 (0.87–1.94) 0.20
Depression 2.04 (1.56–2.67) <0.001 2.08 (1.57–2.77) <0.001 2.03 (1.51–2.72) <0.001 1.57 (1.16–2.13) 0.004
 Late-life 2.59 (1.96–3.41) <0.001 1.97 (1.47–2.63) <0.001 1.90 (1.40–2.57) <0.001 1.46 (1.07–2.00) 0.017
Depression comorbid with anxiety 1.84 (1.10–3.09) 0.02 1.87 (1.09–3.24) 0.024 1.67 (0.93–2.97) 0.08 1.31 (0.73–2.36) 0.36
 Late-life 2.43 (1.44–4.10) 0.001 1.92 (1.11–3.32) 0.02 1.71 (0.95–3.05) 0.07 1.35 (0.75–2.42) 0.32

Model 1 unadjusted.

Model 2 analyses were adjusted for age and sex.

Model 3 analyses were further adjusted for education, ethnicity, and BMI.

Model 4 Analyses were further adjusted for cerebrovascular disease, diabetes, hypertension, coronary artery disease, cancer, and respiratory disease.